Processing Aid · CAS 9001-33-6

Ficin Enzyme

FDA status: Approved. EU: not separately listed. No U.S. state has enacted a specific ban yet.

Low Risk
Score 4 of 5
Ficin Enzyme: 4/5 (Low Risk)

According to the U.S. Food and Drug Administration, Ficin Enzyme is FDA-approved, and no U.S. state has moved to restrict it independently of federal policy. Its composite safety score is 4 out of 5 (Low Risk).

Browse all Processing Aid additives →

The verdict

Ficin Enzyme is FDA-approved, and no U.S. state has moved to restrict it.

4/5
Low Risk
Approved
FDA status
-
EU status
0
state regulations

CAS-led regulatory snapshot

Ficin Enzyme: no OFF product match; CAS 9001-33-6 is the lead registry handle on this row.

Property Value Source
CAS Number 9001-33-6 CAS Registry
FDA Status Approved FDA SAFFA
EU Status Not separately listed EC 1333/2008
E-Number - EU additive register
Category Processing Aid FDA functional class
Composite Safety Score 4 / 5 (Low Risk) PlainIngredients methodology
EFSA ADI Not established EFSA scientific opinion
U.S. State Actions 0 states State legislative records
Tracked Products Not yet tracked Open Food Facts (US)

Values reflect official agency classifications as published by the U.S. Food and Drug Administration and the European Union's regulatory framework. See our methodology for scoring details.

What is Ficin Enzyme?

Ficin Enzyme (CAS 9001-33-6) is an FDA-regulated food substance used as processing aid.

Common Uses

processing aid

Catalog-profile peer axes

Nationwide catalog-profile peers for Ficin Enzyme

Product-count (0) and safety-score (4/5) peer columns, disjoint link sets.

Score 4/5 peers (≥50 OFF products)

Nearest other additives by PlainIngredients safety score (floored at ≥50 tracked products), distinct from the count row.

8 peers

Frequently Asked Questions

Is Ficin Enzyme safe to consume?

Ficin Enzyme scores 4/5 (Low Risk). FDA status is Approved. No OFF product match yet; the distinctive registry handle is CAS 9001-33-6, so this page leads with the chemical identity row rather than a shelf-prevalence claim.